Davis Polk & Wardwell is advising Sibanye Stillwater Limited on the transaction. Sibanye Stillwater Limited (Sibanye-Stillwater) announced its acquisition of Abington Reldan Metals, LLC and certain affiliated companies...
Sibanye-Stillwater’s $211.5 Million Acquisition of Reldan
Banco Santander’s $3.75 Billion Senior Preffered Notes Offering
Davis Polk & Wardwell advised Banco Santander, S.A. on the offering, while Uría Menéndez Abogados and Linklaters advised the underwriters. Banco Santander, S.A. (NYSE:SAN) announced its offering of...
Sociedad Química y Minera de Chile’s $750 Million Green Bonds Offering
Davis Polk & Wardwell advised the representatives of the initial purchasers on the offering. Sociedad Química y Minera de Chile S.A. (NYSE:SQM) announced its $750 million aggregate...
Canadian National Railway’s $600 Million Senior Notes Offering
Davis Polk & Wardwell and Stikeman Elliott advised Canadian National Railway on the offering, and Cravath, Swaine & Moore advised the underwriters. CN (TSX: CNR) (NYSE:...
Harvest Partners’ Closing of HP IX at $5.34 Billion
Davis Polk & Wardwell advised Harvest Partners, LP on the fundraise. Harvest Partners, LP (“Harvest”) announced it has raised $5.34 billion of commitments, surpassing its target of $5.25 billion...
Genuine Parts Company’s $800 Million Senior Notes Offering
King & Spalding advised Genuine Parts Company on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the several underwriters....
Maverick Natural Resources’ $640 Million Securitization
Kirkland & Ellis advised Maverick Natural Resources on the deal, and Sydley Austin advised J.P. Morgan Securities LLC. Maverick Natural Resources (“Maverick”) announced that it has issued $640...
Air Methods’ Chapter 11 Restructuring and Recapitalization
McDermott Will & Emery is advising Wilmington Savings Fund Society, FSB, as the DIP Agent, on the restructuring, Milbank is advising Royal Bank of Canada, as...
GSK’s Licensing Agreement with Hansoh Pharma
Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
UCT’s Acquisition of HIS Innovations Group
Davis Polk & Wardwell advised Ultra Clean Holdings, Inc. on the transaction. Ultra Clean Holdings, Inc. (UCT) announced its acquisition of HIS Innovations Group. UCT paid $50...
IDEAYA Biosciences’ $143.8 Million Common Stock Offering
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
23andMe’s New Data Licensing Agreement with GSK
Davis Polk & Wardwell advised GSK on the deal. 23andMe Holding Co. (Nasdaq: ME) (“23andMe”) announced a new non-exclusive data license with GSK plc (LSE/NYSE: GSK) which...